Lockwood will apply SHG’s healthcare market research expertise to help European-based market research agencies and consultancies reset strategic agendas post-COVID-19 pandemic
NEW YORK, NY February 4, 2020 —SurveyHealthcareGlobus (SHG) has appointed Dan Lockwood as executive vice president for its European Division reporting into the regional managing director Antonio Tropea. SHG—part of the Apollo Intelligence family of companies—is the global market leader of firstparty healthcare data collection and custom survey solutions. Based in London, Dan will help companies access the timely, high-quality life science market insights that are vital to defining their strategic agendas, while supporting SHG’s drive to meet the strong demand as the healthcare industry emerges from the global COVID-19 pandemic.
A seasoned market research leader with over 20 years of experience specifically in the medical research industry, Dan joins SHG most recently from M3 Global Research (M3). As senior vice president of both US and UK operations at M3, he built a reputation for innovation and a boots-on-the ground perspective that enabled client growth. “With COVID-19 demanding that organizations thoughtfully navigate a sea of new challenges as well as opportunities, market research executives deserve experienced and reliable partners who can provide strong vision and a deep understanding of how to reach and engage healthcare stakeholders—assets that Dan Lockwood and SHG have in abundance,” said Daniel S. Fitzgerald, CEO of Apollo Intelligence, parent company to SHG. “We’re delighted to have him on our team where I’m confident he’ll deliver tremendous value to our client partnerships.” “SHG has built a substantial international footprint over the last few years,” said Antonio Tropea, Managing Director, Europe. “The European market has been a strong source of success and growth for us, and the appointment of Daniel only reaffirms our commitment to attracting industry leading talent. We are thrilled to have Daniel onboard. We’re confident he’ll drive our client-first strategy to deliver to high-quality data, products, and services that impact healthcare professionals and patient worldwide.”
Originally from the UK, Dan is well-versed in international healthcare fieldwork services to help healthcare leaders develop and implement strategic and proactive research insights on a global scale. Prior to M3, Dan served as senior vice president for New York City-based Medefield, and before that, he rose through the ranks at Kantar’s All Global unit in the UK in operational and business development leadership roles.